IPO Valuation Explained: Why New Stocks Often Need to Be Sold at a Discount

A private company may believe it is worth $20 billion.

Public-market investors may disagree.

That gap is one of the biggest challenges in IPO valuation.

The U.S. IPO market recently slowed as higher bond yields reduced risk appetite. Reuters reported that only four companies had gone public after Labor Day by September 25, while investors were demanding a clearer IPO discount from issuers.

The lesson is simple:

A private valuation does not automatically become a public-market valuation.

Why IPOs Are Often Sold at a Discount

Investors buying a new stock face uncertainty.

The company may have:

  • limited public trading history
  • uncertain earnings forecasts
  • concentrated ownership
  • unfamiliar management
  • limited price discovery

Because of that uncertainty, investors often want to buy below what they believe the company could eventually be worth.

The SEC notes that underpricing can increase demand for an IPO and help ensure all available shares are sold.

That discount compensates investors for taking early risk.

How Bookbuilding Finds the Price

Before an IPO starts trading, investment banks speak with institutional investors.

Investors indicate:

  • how many shares they want
  • what price they are willing to pay
  • how sensitive their demand is to valuation

This process is called bookbuilding.

The NYSE explains that banks use this order book, along with investor feedback and market conditions, to recommend the final IPO price.

Imagine investors say:

$30 per share → huge demand

$35 → moderate demand

$40 → weak demand

The company may price near $33–$35 rather than push for $40 and risk a poor launch.

Why Private Valuations Can Be Misleading

Private companies raise money in negotiated funding rounds.

Those valuations may have been set when:

  • interest rates were lower
  • technology stocks were more expensive
  • investor risk appetite was stronger

Public markets constantly reprice companies.

That means an old private valuation may no longer reflect current conditions.

Reuters recently described exactly this problem: issuers were still targeting valuations formed in a stronger market, while buyers wanted larger discounts.

What Causes the First-Day “Pop”?

Suppose an IPO is priced at:

$20

Then starts trading at:

$24

That is a:

20% first-day gain

Part of that move can come from intentional underpricing.

Banks want enough demand for the stock to trade well after listing.

But a huge first-day jump can also mean the company priced its shares too cheaply and left money on the table.

The SEC specifically notes this trade-off: investors may enjoy the initial rise, while the company may regret not selling shares at a higher price.

Why Lockups Matter

Founders, employees and early investors usually cannot sell all their shares immediately.

They often agree to an IPO lock-up period, commonly around 180 days.

That limits the number of shares available for trading at first.

When the lockup expires, more stock may enter the market.

That can create:

more share supply → potential price pressure

Investors therefore need to watch not only IPO pricing, but also what happens months later.

Expected Return vs Risk

A successful IPO is not simply one that rises on day one.

Investors should compare price with the company’s long-term economics.

FactorWhy It Matters
Revenue growthShows business expansion
ProfitabilityShows economic quality
IPO discountProvides valuation cushion
First-day returnShows initial demand
Lockup expiryCan increase share supply
Public peersProvide valuation benchmarks

The most important question is:

What future return is implied by the price investors pay today?

The Bottom Line

IPO valuation is a negotiation between sellers who want the highest price and buyers who want enough upside to justify taking risk.

The process is roughly:

private valuation → investor feedback → bookbuilding → IPO discount → public trading

That is why even excellent companies sometimes need to list below their previous private valuation.

A lower IPO price is not necessarily a sign of weakness.

Sometimes it is simply the price required to balance expected return with risk.

For more trend analysis, valuation research and model-driven market tools, sign up to TradingSimuLab and explore the Trend Detector alongside the wider five-model research framework.


SEO Title: IPO Valuation Explained: Why New Stocks Often Sell at a Discount

Slug: ipo-valuation-discount-bookbuilding

Meta Description: Learn how IPO valuation works, why new stocks are often discounted, and how bookbuilding, first-day returns and lockups affect investors.

Primary Keyphrase: IPO valuation

Secondary Keyphrases: IPO discount, IPO pricing, bookbuilding, first-day return, IPO lockup period, private market valuation, public market valuation, IPO investing

Continue exploring TradingSimuLab.

  • Mining Stocks: Why Big Miners Keep Trying to Merge

    Building a new mine can cost billions and take more than a decade. That is one reason large mining companies keep trying to merge. Reuters reports that new copper projects can require $10–$20 billion of investment, pushing miners toward larger balance sheets, partnerships and acquisitions. Gold Fields recently had a $27.1 billion offer for Northern…

  • Bitcoin Mining Stocks: Why Power May Be More Valuable Than Mining

    Bitcoin miners spent years securing one scarce resource: electricity. Now that power may be worth more to AI companies than to bitcoin mining itself. Several bitcoin mining stocks are shifting toward AI data centers by leasing sites with large grid connections. Reuters Breakingviews estimates crypto miners control roughly 14 gigawatts of operational and planned U.S.…

  • Data Center Infrastructure Stocks: The AI Picks-and-Shovels Trade

    The AI boom is usually associated with GPUs and semiconductor stocks. But every AI chip also needs: That is creating a second investment theme around data center infrastructure stocks. Reuters reports that global data-center investment could approach $7 trillion by 2030, while shortages of transformers, grid connections and cooling equipment are already slowing some projects.…

  • Oil Stocks: Dividends, Buybacks or New Projects?

    When oil companies generate huge amounts of cash, they face a simple question: What should they do with it? They can: That decision matters enormously for oil stocks. The five largest Western oil majors — BP, Chevron, Exxon Mobil, Shell and TotalEnergies — are expected to generate roughly $53 billion of combined third-quarter profit, according…

  • Refining Margins Explained: Why Oil Companies Can Profit Without Producing More Oil

    Oil companies do not only make money by producing crude. Many also earn large profits by turning crude oil into gasoline, diesel and jet fuel. That is where refining margins matter. Reuters recently reported that benchmark U.S. crack spreads averaged about $63 per barrel in the third quarter of 2026, up from $50 in the…

  • Insurance Stocks Explained: How Underwriting Turns Risk Into Profit

    Insurance companies make money by doing something unusual: They get paid today for losses that may happen later. That is the core economics behind insurance stocks. The Fidelis Partnership recently filed for a U.S. IPO after reporting $127.5 million of net income on $407.5 million of revenue for the first half of 2026, up from…

  • Private Equity Exits Explained: Why High Rates Can Trap Investors for Years

    Private equity firms do not make money simply by buying companies. Eventually, they need to sell them. That is why private equity exits matter so much. Warburg Pincus has realized roughly $12 billion of exits in 2026, matching its record total from last year, even though weak software markets and volatile equities have made IPO…

  • IPO Valuation Explained: Why New Stocks Often Need to Be Sold at a Discount

    A private company may believe it is worth $20 billion. Public-market investors may disagree. That gap is one of the biggest challenges in IPO valuation. The U.S. IPO market recently slowed as higher bond yields reduced risk appetite. Reuters reported that only four companies had gone public after Labor Day by September 25, while investors…

  • Biotech Licensing Deals: Why Pharma Pays Billions for Unapproved Drugs

    Pharmaceutical companies sometimes agree to deals worth billions for drugs that have never reached the market. That sounds risky. It is. But biotech licensing deals are usually designed so that much of the money is paid only if the drug succeeds. Novo Nordisk recently agreed to pay China’s Hengrui $300 million upfront for rights to…